Cancer Care Day
Shaping the Future of Cancer Care
ECR - February 26, 2025
The future of cancer care is shaped by technological innovation and a strong patient focus. The goal of Siemens Healthineers is to transform Cancer Care and create a world without fear of cancer together with our customers. With more than 520 participants, Cancer Care Day at ECR 2024 was a great success. At ECR 2025, Cancer Care Day will address the topic Shaping the Future of Cancer Care. During the opening panel discussion, we will focus on new advancements and future-shaping trends in Cancer Care. This will be followed by a choice of four scientific symposia and a panel discussion on breast, prostate, liver and lung cancer.
10:30 am - 12:00 pm | Room K2
Speaker: Stefan Schönberg, Angela Aristidou, +2
In this panel discussion, experts will highlight the increasing importance of integrating diagnostics, personalized therapy, and artificial intelligence along the entire continuum of care.
1:00 pm - 2:00 pm | Room K2
Speaker: Daniel Bernardi, Isabelle Thomassin-Naggara, +2
Breast screening programs have been a key topic of discussion for nearly 50 years. New findings from scientific studies combined with technological advancements continue to spark new debates. It often feels like every answered question raises two new ones.
1:00 pm - 2:00 pm | Room K1
Speaker: Francesco Giganti, Anwar Padhani, +2
Recent technical innovations in prostate MRI have sparked significant excitement and debate within the clinical community. Join us for an engaging session with renowned experts who will explore how these advancements are shaping the future of prostate MRI and improving patient care.
2:30 pm - 3:30 pm | Room K2
Speaker: Freba Grawe, René Werner, +1
Explore the complexities of lung cancer diagnosis beyond routine screening, delving into innovative approaches, interdisciplinary insights, and the challenges of early and accurate detection.
2:30 pm - 3:30 pm | Room K1
Speaker: Saif Afat, Thomas Reiberger, +1
This symposium brings together leading experts in hepatology, radiology, and interventional imaging to discuss the latest advancements in the diagnosis, staging, and treatment of liver diseases and liver cancer.
Are you interested?
Share
Do you find this page interesting? Share the information with peers.
Related links
Partner Bayer